LPCNLipocine Inc.
Earnings
When Lipocine Inc. reports, what it reported each quarter, and how the stock took the results.
61 quarters. Sep 30, 2011 to Sep 30, 2026. USD.
Next results · Q4 2026Projected
Mar 9, before the open
Tue, Mar 9, 2027in 113 days
Projected from its last 8 releases. The company has not named the day yet.
- Quarter
- Q4 2026 · Ends about Dec 31, 2026
- 10-K window
- Mar 5 – 16
Read against Q4 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- $1.15M
- Revenue, change from a year earlier: Q3 2026 +1,898.8%, Q2 2026 −69.5%, Q1 2026 +27.2%, Q4 2025 −67.2%
- Net income
- -$2.37M
- Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
- EPS
- —
- EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m
Latest results
- Revenue
- $2.29M
- +1,898.8%
- Net income
- -$666.19K
- N/M
- EPS
- -$0.08
- N/M
- Revenue
- $190.10K
- −69.5%
- Net income
- -$2.62M
- N/M
- EPS
- -$0.32
- N/M
- Revenue
- $119.40K
- +27.2%
- Net income
- -$3.67M
- N/M
- EPS
- -$0.54
- N/M
- Revenue
- $1.15M
- −67.2%
- Net income
- -$2.37M
- N/M
- EPS
- —
- —
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q3 2026 | Sep 30, 2026 | Nov 5, 2026 · market hours | Nov 5, 2026 | 36 d | 10-Q | $2.29M | +1,898.8% | -$0.08 | +4.8% | |
| Q2 2026 | Jun 30, 2026 | Aug 4, 2026 · pre-market | Aug 4, 2026 | 35 d | 10-Q | $190.10K | −69.5% | -$0.32 | +3.3% | |
| Q1 2026 | Mar 31, 2026 | May 7, 2026 · pre-market | May 7, 2026 | 37 d | 10-Q | $119.40K | +27.2% | -$0.54 | 1.2% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | Mar 10, 2026 · pre-market | Mar 10, 2026 | 69 d | 10-K | $1.15M | −67.2% | — | +1.4% | |
| Q3 2025 | Sep 30, 2025 | Nov 6, 2025 · market hours | Nov 6, 2025 | 37 d | 10-Q | $114.57K | — | -$0.59 | — | |
| Q2 2025 | Jun 30, 2025 | Aug 5, 2025 · pre-market | Aug 5, 2025 | 36 d | 10-Q | $622.85K | +595.4% | -$0.41 | 2.5% | |
| Q1 2025 | Mar 31, 2025 | — | May 8, 2025 | 38 d | 10-Q | $93.86K | −98.8% | -$0.35 | 1.3% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | — | Mar 13, 2025 | 72 d | 10-K | $3.49M | +1,515.0% | — | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 7, 2024 | 38 d | 10-Q | — | — | -$0.44 | 20.5% | |
| Q2 2024 | Jun 30, 2024 | — | Aug 8, 2024 | 39 d | 10-Q | $89.57K | — | -$0.56 | 11.4% | |
| Q1 2024 | Mar 31, 2024 | — | May 9, 2024 | 39 d | 10-Q | $7.62M | +13,751.9% | $0.66 | — | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | Mar 7, 2024 · pre-market | Mar 7, 2024 | 67 d | 10-K | $216.19K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 8, 2023 | 39 d | 10-Q | -$3.12M | — | -$1.27 | +9.7% | |
| Q2 2023 | Jun 30, 2023 | — | Aug 10, 2023 | 41 d | 10-Q | $0.00 | −100.0% | -$0.68 | — | |
| Q1 2023 | Mar 31, 2023 | — | May 11, 2023 | 41 d | 10-Q | $54.99K | — | -$0.76 | +1,600.0% | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | — | Mar 10, 2023 | 69 d | 10-K | $0.00 | — | — | 26.2% | |
| Q3 2022 | Sep 30, 2022 | — | Nov 9, 2022 | 40 d | 10-Q | — | — | -$0.52 | — | |
| Q2 2022 | Jun 30, 2022 | — | Aug 8, 2022 | 39 d | 10-Q | $500.00K | — | -$0.61 | — | |
| Q1 2022 | Mar 31, 2022 | — | May 9, 2022 | 39 d | 10-Q | — | — | -$0.04 | — | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | — | Mar 9, 2022 | 68 d | 10-K | — | — | — | 0.7% | |
| Q3 2021 | Sep 30, 2021 | — | Nov 10, 2021 | 41 d | 10-Q | $54.99K | — | -$0.04 | 0.8% | |
| Q2 2021 | Jun 30, 2021 | — | Aug 5, 2021 | 36 d | 10-Q | — | — | -$0.08 | — | |
| Q1 2021 | Mar 31, 2021 | — | May 6, 2021 | 36 d | 10-Q | — | — | -$0.04 | 1.4% | |
| FY 2020 | ||||||||||
| Q4 2020 | Dec 31, 2020 | Jan 25, 2021 · after-hours | Mar 11, 2021 | 70 d | 10-K | $0.00 | — | — | 10.0% | |
| Q3 2020 | Sep 30, 2020 | — | Nov 10, 2020 | 41 d | 10-Q | $0.00 | −100.0% | -$0.07 | +4.9% | |
| Q2 2020 | Jun 30, 2020 | — | Aug 6, 2020 | 37 d | 10-Q | — | — | -$0.13 | +12.3% | |
| Q1 2020 | Mar 31, 2020 | — | May 7, 2020 | 37 d | 10-Q | — | — | -$0.14 | +8.1% | |
| FY 2019 | ||||||||||
| Q4 2019derived | Dec 31, 2019 | — | Mar 13, 2020 | 73 d | 10-K | $0.00 | — | — | 11.9% | |
| Q3 2019 | Sep 30, 2019 | — | Nov 12, 2019 | 43 d | 10-Q | $164.99K | — | -$0.12 | — | |
| Q2 2019 | Jun 30, 2019 | — | Aug 7, 2019 | 38 d | 10-Q | $0.00 | — | -$0.14 | — | |
| Q1 2019 | Mar 31, 2019 | — | May 8, 2019 | 38 d | 10-Q | $0.00 | −100.0% | -$0.14 | — | |
| FY 2018 | ||||||||||
| Q4 2018 | Dec 31, 2018 | — | Mar 6, 2019 | 65 d | 10-K | $0.00 | — | -$0.15 | +9.4% | |
| Q3 2018 | Sep 30, 2018 | — | Nov 7, 2018 | 38 d | 10-Q | $0.00 | — | -$0.12 | +8.1% | |
| Q2 2018 | Jun 30, 2018 | — | Aug 7, 2018 | 38 d | 10-Q | $0.00 | — | -$0.15 | — | |
| Q1 2018 | Mar 31, 2018 | — | May 7, 2018 | 37 d | 10-Q | $428.03K | — | -$0.13 | +6.8% | |
| FY 2017 | ||||||||||
| Q4 2017 | Dec 31, 2017 | — | Mar 12, 2018 | 71 d | 10-K | $0.00 | — | -$0.25 | 6.3% | |
| Q3 2017 | Sep 30, 2017 | Nov 8, 2017 · pre-market | Nov 8, 2017 | 39 d | 10-Q | $0.00 | — | -$0.22 | — | |
| Q2 2017 | Jun 30, 2017 | Aug 7, 2017 · pre-market | Aug 7, 2017 | 38 d | 10-Q | $0.00 | — | -$0.31 | — | |
| Q1 2017 | Mar 31, 2017 | May 8, 2017 · pre-market | May 8, 2017 | 38 d | 10-Q | $0.00 | — | -$0.26 | 6.1% | |
| FY 2016 | ||||||||||
| Q4 2016 | Dec 31, 2016 | Mar 6, 2017 · after-hours | Mar 6, 2017 | 65 d | 10-K | — | — | -$0.16 | — | |
| Q3 2016 | Sep 30, 2016 | Nov 8, 2016 · pre-market | Nov 8, 2016 | 39 d | 10-Q | — | — | -$0.18 | +13.0% | |
| Q2 2016 | Jun 30, 2016 | Aug 9, 2016 · pre-market | Aug 9, 2016 | 40 d | 10-Q | — | — | -$0.32 | +17.1% | |
| Q1 2016 | Mar 31, 2016 | May 9, 2016 · after-hours | May 9, 2016 | 39 d | 10-Q | — | — | -$0.38 | 4.5% | |
| FY 2015 | ||||||||||
| Q4 2015 | Dec 31, 2015 | Mar 10, 2016 · after-hours | Mar 10, 2016 | 70 d | 10-K | — | — | -$0.25 | — | |
| Q3 2015 | Sep 30, 2015 | Nov 12, 2015 · after-hours | Nov 12, 2015 | 43 d | 10-Q | — | — | -$0.35 | +28.9% | |
| Q2 2015 | Jun 30, 2015 | Aug 11, 2015 · pre-market | Aug 11, 2015 | 42 d | 10-Q | — | — | -$0.26 | — | |
| Q1 2015 | Mar 31, 2015 | May 7, 2015 · pre-market | May 7, 2015 | 37 d | 10-Q | — | — | -$0.23 | +2.0% | |
| FY 2014 | ||||||||||
| Q4 2014derived | Dec 31, 2014 | Mar 11, 2015 · pre-market | Mar 11, 2015 | 70 d | 10-K | — | — | — | 11.6% | |
| Q3 2014 | Sep 30, 2014 | Nov 10, 2014 · pre-market | Nov 10, 2014 | 41 d | 10-Q | — | — | -$0.32 | +22.2% | |
| Q2 2014 | Jun 30, 2014 | Aug 13, 2014 · after-hours | Aug 13, 2014 | 44 d | 10-Q | — | — | -$0.55 | +2.7% | |
| Q1 2014 | Mar 31, 2014 | — | May 13, 2014 | 43 d | 10-Q | — | — | -$0.41 | +4.0% | |
| FY 2013 | ||||||||||
| Q4 2013derived | Dec 31, 2013 | — | Mar 31, 2014 | 90 d | 10-K | — | — | — | +4.5% | |
| Q3 2013 | Sep 30, 2013 | — | Nov 13, 2013 | 44 d | 10-Q | $0.00 | — | -$0.39 | 7.2% | |
| Q2 2013 | Jun 30, 2013 | — | Jul 9, 2013 | 9 d | 10-Q | — | — | -$0.31 | — | |
| Q1 2013 | Mar 31, 2013 | — | Apr 24, 2013 | 24 d | 10-Q | — | — | -$0.30 | — | |
| FY 2012 | ||||||||||
| Q4 2012derived | Dec 31, 2012 | — | Feb 26, 2013 | 57 d | 10-K | — | — | — | — | |
| Q3 2012 | Sep 30, 2012 | — | Oct 26, 2012 | 26 d | 10-Q | $0.00 | — | -$0.23 | — | |
| Q2 2012 | Jun 30, 2012 | — | Jul 18, 2012 | 18 d | 10-Q | — | — | — | — | |
| Q1 2012 | Mar 31, 2012 | — | May 14, 2012 | 44 d | 10-Q | — | — | -$0.02 | — | |
| FY 2011 | ||||||||||
| Q4 2011 | Dec 31, 2011 | — | Mar 5, 2012 | 65 d | 10-K | — | — | — | — | |
| Q3 2011 | Sep 30, 2011 | — | — | — | — | $0.00 | — | $0.00 | — | |
Earlier years, FY 2011 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR